Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Oct 13;301(6756):842–845. doi: 10.1136/bmj.301.6756.842

Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial.

T R Tubman 1, H L Halliday 1, C Normand 1
PMCID: PMC1663955  PMID: 2126475

Abstract

OBJECTIVE--To estimate the cost of treating babies with severe respiratory distress syndrome with natural porcine surfactant. DESIGN--Retrospective controlled survey. SETTING--Regional neonatal intensive care unit, Belfast. PATIENTS--33 Preterm babies with severe respiratory distress syndrome who were enrolled in a European multicentre trial during 1985-7. 19 Babies were treated with surfactant and 14 served as controls. INTERVENTIONS--Treatment with natural porcine surfactant. MAIN OUTCOME MEASURE--Cost associated with surfactant replacement treatment per extra survivor in the treatment group and cost per quality adjusted life year for each extra survivor. RESULTS--Fifteen (79%) of the 19 treated babies and five (36%) of the 14 control babies survived. On average, the control babies required 20 days in hospital compared with 61 days for the treated babies (or 95 [corrected] days per extra survivor in the treatment group). The cost per extra survivor in the treatment group was pounds 13,720, with the cost per quality adjusted life year estimated at pounds 710. CONCLUSION--These costs compare favourably with those of established forms of treatment in adults. Thus surfactant replacement treatment for severe respiratory distress syndrome is fairly inexpensive and cost effective.

Full text

PDF
842

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyle M. H., Torrance G. W., Sinclair J. C., Horwood S. P. Economic evaluation of neonatal intensive care of very-low-birth-weight infants. N Engl J Med. 1983 Jun 2;308(22):1330–1337. doi: 10.1056/NEJM198306023082206. [DOI] [PubMed] [Google Scholar]
  2. Enhorning G., Shennan A., Possmayer F., Dunn M., Chen C. P., Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics. 1985 Aug;76(2):145–153. [PubMed] [Google Scholar]
  3. Maniscalco W. M., Kendig J. W., Shapiro D. L. Surfactant replacement therapy: impact on hospital charges for premature infants with respiratory distress syndrome. Pediatrics. 1989 Jan;83(1):1–6. [PubMed] [Google Scholar]
  4. Mugford M. A review of the economics of care for sick newborn infants. Community Med. 1988 May;10(2):99–111. [PubMed] [Google Scholar]
  5. Newns B., Drummond M. F., Durbin G. M., Culley P. Costs and outcomes in a regional neonatal intensive care unit. Arch Dis Child. 1984 Nov;59(11):1064–1067. doi: 10.1136/adc.59.11.1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ryan S., Sics A., Congdon P. Cost of neonatal care. Arch Dis Child. 1988 Mar;63(3):303–306. doi: 10.1136/adc.63.3.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sandhu B., Stevenson R. C., Cooke R. W., Pharoah P. O. Cost of neonatal intensive care for very-low-birthweight infants. Lancet. 1986 Mar 15;1(8481):600–603. doi: 10.1016/s0140-6736(86)92820-5. [DOI] [PubMed] [Google Scholar]
  8. Williams A. Economics of coronary artery bypass grafting. Br Med J (Clin Res Ed) 1985 Aug 3;291(6491):326–329. doi: 10.1136/bmj.291.6491.326. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES